SCHEMBL18705485

SCHEMBL18705485

CCc1ccc2[nH]c3c(OC)c4[nH]c5ccc(C)cc5c4cc3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
MAPT P10636 5/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HSD17B10 Q99714 2/20 0.40
MCL1 Q07820 2/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 4/20 0.40
GAA P10253 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
LMNA P02545 1/20 0.38
KIF11 P52732 2/20 0.38
HTR2B P41595 1/20 0.38
ACHE P22303 1/20 0.37
PKM P14618 1/20 0.37
IDE P14735 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1921071 0.88 KDM4E (0.47) KDM4EMAPTMAPK1SMN1; SMN2HSD17B10
SCHEMBL13019107 0.82 KIF11 (0.53) KDM4EMAPTSMN1; SMN2HSD17B10NPC1
SCHEMBL31549971 0.82 KIF11 (0.53) KDM4EMAPTSMN1; SMN2HSD17B10NPC1
SCHEMBL18705463 0.81 KDM4E (0.57) KDM4EMAPTMAPK1SMN1; SMN2HSD17B10
Sr-13668 SCHEMBL29381258 0.73 KDM4E (0.64) KDM4EMAPTMAPK1SMN1; SMN2HSD17B10
Sr-13668 SCHEMBL30173443 0.73 KDM4E (0.64) KDM4EMAPTMAPK1SMN1; SMN2HSD17B10
Sr-13668 SCHEMBL1071997 0.73 KDM4E (0.64) KDM4EMAPTMAPK1SMN1; SMN2HSD17B10
SCHEMBL5494899 0.73 KIF11 (0.62) KDM4EMAPTSMN1; SMN2HSD17B10NPC1
SCHEMBL30458204 0.73 KIF11 (0.62) KDM4EMAPTSMN1; SMN2HSD17B10NPC1
SCHEMBL23403853 0.72 KDM4E (0.48) KDM4EMAPTMAPK1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170095450-A1 Lipoxygenase Inhibitors SRI INTERNATIONAL 2017-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170095450-A1 Lipoxygenase Inhibitors ALOX15B, ALOX12, ALOX15 KDM4E 3048/4885MAPT 436/4885MAPK1 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.